Thailand vs Togo: Access to anti-retroviral drugs, male
Thailand
86.0%
in 2024
Togo
86.0%
in 2024
Thailand rank
30th
Togo rank
30th
Access to anti-retroviral drugs, male over time
- Thailand
- Togo
How they compare
Thailand currently reports 86.0% against 86.0% in Togo, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Togo ahead.
Thailand ranks 30th and Togo ranks 30th of 141 countries.
Thailand has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Thailand | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.4% | 6.1% | 4.3% | Thailand |
| 2010s | 50.6% | 37.6% | 13.0% | Thailand |
| 2020s | 80.0% | 74.2% | 5.8% | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Thailand or Togo?
- Thailand, at 86.0% against 86.0% in Togo as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Thailand and Togo?
- 0.0%, with Thailand ahead.
- How many years of comparable data are there for Thailand and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Thailand and Togo rank globally for access to anti-retroviral drugs, male?
- Thailand ranks 30th and Togo ranks 30th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.